vs

Side-by-side financial comparison of Public Storage (PSA) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Public Storage is the larger business by last-quarter revenue ($1.2B vs $622.0M, roughly 2.0× Royalty Pharma plc). Public Storage runs the higher net margin — 41.7% vs 34.4%, a 7.3% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 3.3%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 2.5%).

Public Storage, headquartered in Glendale, California, is a real estate investment trust that invests in self storage. It is the largest brand of self-storage services in the US and owns approximately 9% of the self storage square footage in the U.S. As of December 31, 2024, the company operated 3,073 self-storage facilities containing an aggregate of 221 million net rentable square feet of space.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

PSA vs RPRX — Head-to-Head

Bigger by revenue
PSA
PSA
2.0× larger
PSA
$1.2B
$622.0M
RPRX
Growing faster (revenue YoY)
RPRX
RPRX
+1.5% gap
RPRX
4.8%
3.3%
PSA
Higher net margin
PSA
PSA
7.3% more per $
PSA
41.7%
34.4%
RPRX
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
2.5%
PSA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PSA
PSA
RPRX
RPRX
Revenue
$1.2B
$622.0M
Net Profit
$507.1M
$214.2M
Gross Margin
Operating Margin
40.7%
62.4%
Net Margin
41.7%
34.4%
Revenue YoY
3.3%
4.8%
Net Profit YoY
-17.5%
2.9%
EPS (diluted)
$2.59
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PSA
PSA
RPRX
RPRX
Q4 25
$1.2B
$622.0M
Q3 25
$1.2B
$609.3M
Q2 25
$1.2B
$578.7M
Q1 25
$1.2B
$568.2M
Q4 24
$1.2B
$593.6M
Q3 24
$1.2B
$564.7M
Q2 24
$1.2B
$537.3M
Q1 24
$1.2B
$568.0M
Net Profit
PSA
PSA
RPRX
RPRX
Q4 25
$507.1M
$214.2M
Q3 25
$511.1M
$288.2M
Q2 25
$358.4M
$30.2M
Q1 25
$407.8M
$238.3M
Q4 24
$614.6M
$208.2M
Q3 24
$430.3M
$544.0M
Q2 24
$518.1M
$102.0M
Q1 24
$508.9M
$4.8M
Operating Margin
PSA
PSA
RPRX
RPRX
Q4 25
40.7%
62.4%
Q3 25
42.3%
70.1%
Q2 25
30.4%
36.3%
Q1 25
34.8%
94.0%
Q4 24
52.4%
60.9%
Q3 24
36.7%
Q2 24
44.6%
50.2%
Q1 24
44.3%
-13.0%
Net Margin
PSA
PSA
RPRX
RPRX
Q4 25
41.7%
34.4%
Q3 25
41.8%
47.3%
Q2 25
29.8%
5.2%
Q1 25
34.5%
41.9%
Q4 24
52.2%
35.1%
Q3 24
36.2%
96.3%
Q2 24
44.2%
19.0%
Q1 24
44.0%
0.8%
EPS (diluted)
PSA
PSA
RPRX
RPRX
Q4 25
$2.59
$0.49
Q3 25
$2.62
$0.67
Q2 25
$1.76
$0.07
Q1 25
$2.04
$0.55
Q4 24
$3.22
$0.46
Q3 24
$2.16
$1.21
Q2 24
$2.66
$0.23
Q1 24
$2.60
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PSA
PSA
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$318.1M
$618.7M
Total DebtLower is stronger
$10.3B
$9.0B
Stockholders' EquityBook value
$9.2B
$9.7B
Total Assets
$20.2B
$19.6B
Debt / EquityLower = less leverage
1.11×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PSA
PSA
RPRX
RPRX
Q4 25
$318.1M
$618.7M
Q3 25
$296.5M
$938.9M
Q2 25
$1.1B
$631.9M
Q1 25
$287.2M
$1.1B
Q4 24
$447.4M
$929.0M
Q3 24
$599.0M
$950.1M
Q2 24
$542.3M
$1.8B
Q1 24
$271.6M
$843.0M
Total Debt
PSA
PSA
RPRX
RPRX
Q4 25
$10.3B
$9.0B
Q3 25
$10.0B
$8.9B
Q2 25
$10.4B
$8.0B
Q1 25
$9.4B
$7.6B
Q4 24
$9.4B
$7.6B
Q3 24
$9.5B
$7.6B
Q2 24
$9.4B
$7.6B
Q1 24
$9.1B
$6.1B
Stockholders' Equity
PSA
PSA
RPRX
RPRX
Q4 25
$9.2B
$9.7B
Q3 25
$9.3B
$9.6B
Q2 25
$9.4B
$9.5B
Q1 25
$9.6B
$9.8B
Q4 24
$9.7B
$10.3B
Q3 24
$9.6B
$10.3B
Q2 24
$9.7B
$9.8B
Q1 24
$9.9B
$9.9B
Total Assets
PSA
PSA
RPRX
RPRX
Q4 25
$20.2B
$19.6B
Q3 25
$20.1B
$19.3B
Q2 25
$20.5B
$18.3B
Q1 25
$19.6B
$17.6B
Q4 24
$19.8B
$18.2B
Q3 24
$19.8B
$18.0B
Q2 24
$19.8B
$17.7B
Q1 24
$19.6B
$16.1B
Debt / Equity
PSA
PSA
RPRX
RPRX
Q4 25
1.11×
0.92×
Q3 25
1.08×
0.93×
Q2 25
1.11×
0.84×
Q1 25
0.99×
0.78×
Q4 24
0.96×
0.74×
Q3 24
0.99×
0.74×
Q2 24
0.97×
0.78×
Q1 24
0.91×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PSA
PSA
RPRX
RPRX
Operating Cash FlowLast quarter
$733.6M
$827.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.45×
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PSA
PSA
RPRX
RPRX
Q4 25
$733.6M
$827.1M
Q3 25
$875.1M
$702.6M
Q2 25
$872.7M
$364.0M
Q1 25
$705.1M
$596.1M
Q4 24
$768.6M
$742.5M
Q3 24
$798.8M
$703.6M
Q2 24
$895.3M
$658.2M
Q1 24
$665.6M
$664.6M
Cash Conversion
PSA
PSA
RPRX
RPRX
Q4 25
1.45×
3.86×
Q3 25
1.71×
2.44×
Q2 25
2.43×
12.06×
Q1 25
1.73×
2.50×
Q4 24
1.25×
3.57×
Q3 24
1.86×
1.29×
Q2 24
1.73×
6.45×
Q1 24
1.31×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PSA
PSA

Self Storage Operations$1.1B93%
Ancillary Operations$86.9M7%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons